“…previously detailed (Belghit et al, 2014) using the following antibodies: anti-phospho-ribosomal protein S6 (S6 Ser235/Ser236, 4856, Cell Signaling Technologies); anti-carboxyl terminal S6 (2217, Cell Signaling Technologies); anti-phospho-eukaryotic translation initiation factor 2α (eIF2α Ser51, 9721, Cell Signaling Technology); anti-carboxyl terminal eIF2α (9722, Cell Signaling Technology); anti-β-tubulin (2146, Cell Signaling Technology); anti-translocase of inner mitochondrial membrane 23 (TIM23, 611222, BD Transduction Laboratories TM ), anti-mitofusin2 (MFN2, ab56889, Abcam); anti-parkin RBR E3 ubiquitin protein ligase (PARKIN, ab15954, Abcam); anti-phospho-ubiquitin (Ser65) (Ser65, ABS1513-I, EMD Millipore); anti-total ubiquitin (MAB1510, EMD Millipore); and anti-cleaved poly (ADP-ribose) polymerase (PARP, 95425, Cell Signaling Technology). All of these antibodies (except anti-cleaved PARP) have already been validated in rainbow trout (Belghit et al, 2014;Seiliez et al, 2016;Séité et al, 2018). For cleaved PARP, the amino sequence of the corresponding protein was monitored in the SIGENAE database (http://www.sigenae.org) to check for the conservation of the antigen sequence with the corresponding sequence from mammals, ensuring a good specificity of the mammalian antibody used in the analysis of our samples.…”